Scientific Literature v2
Selected and regularly updated scholarly publications of original empirical and theoretical work on thalassaemia and sickle cell disease (SCD), presented in chronological order.
- All
- Blood
- Bone disease
- Sickle Cell Disease
- TIF Literature
- Liver
- Epidemiology
- Cardiac complications
- Iron Chelation & Overload
- Endocrine system
- Nutrition
- Survival
- Hematopoietic Stem Cell Transplantation
- Preimplantation Genetic Diagnosis
- Gene Therapy and Gene Editing
- New Therapeutical Approaches
- Prevention
- Non-Transfusion Dependent Thalassaemias
- α-thalassaemia
- Renal Complications
- Nurses
- Pregnancy
Efficacy and Safety οf Mitapivat in Adults with Transfusion-Dependent Α-Thalassaemia or Β-Thalassaemia (ENERGIZE-T): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial
Cappellini, M. D., Sheth, S., Taher, A., Al-Samkari, H., Antmen, A. B., Beneitez, D., Cannas, G., et al. Lancet (London, England), 408(10559), 1010–1018. https://doi.org/10.1016/S0140-6736(26)00874-3 (2026)
Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy
Sharma, A., Kassim, A., Thompson, A., Williams, D. A., Liu, H. D., Boelens, J. J. & Cancio, M. I. Transplantation and cellular therapy. (2026)
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial
Musallam, K. M., Cappellini, M. D., Kattamis, A., Dyer, M., Hnoosh, A., Eliason, L., & Taher, A. T. European Journal of Haematology, 117(1), 161-173. (2026)
Prevalence of Severe Thalassemia and Performance of Prenatal Screening Tests Among Pregnant Women at Siriraj Thalassemia Center in Thailand
Malasai, K., Chaikledkaew, U., Talungchit, P., Youngkong, S., Udomsinprasert, W., Limwongse, C., & Jittikoon, J. Clinical and Translational Science, 19(2), e70485. (2026)
A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization
de Sanctis, V., Daar, S., Tzoulis, P., Soliman, A. T., Modeva, I., Kattamis, C. et al. Mediterranean Journal of Hematology and Infectious Diseases, 18(1), e2026035. (2026)
Red Cell Specifications for Blood Group Matching in Patients With Haemoglobinopathies: An Updated Systematic Review and Clinical Practice Guideline from the International Collaboration for Transfusion Medicine Guidelines
Wolf, J., Blais‐Normandin, I., Bathla, A., Keshavarz, H., Chou, S. T., Al‐Riyami, A. Z. et al. British journal of haematology, 206(1), 94-108. (2025)
Efficacy and Safety of Early-start Deferiprone in Infants and Young Children with Transfusion-dependent Beta Thalassemia: Evidence for Iron Shuttling to Transferrin in a Randomized, Double-blind, Placebo-controlled, Clinical Trial (START)
Elalfy, M.S., Hamdy, M., Adly, A., Ebeid, F.S., et al. American Journal of Hematology. (2023)
Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-dependent β-Thalassemia (TDT): A Long-term Retrospective Analysis
De Sanctis, V., Soliman, A. T., Tzoulis, P., Daar, S., Di Maio, et al. Mediterranean Journal of Hematology and Infectious Diseases, 13(1). (2021)